blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3119755

EP3119755 - ANTIFUNGAL COMPOUND PROCESS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.01.2020
Database last updated on 05.10.2024
FormerThe patent has been granted
Status updated on  01.02.2019
FormerGrant of patent is intended
Status updated on  09.09.2018
FormerExamination is in progress
Status updated on  16.03.2018
FormerRequest for examination was made
Status updated on  23.12.2016
FormerThe international publication has been made
Status updated on  30.11.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Mycovia Pharmaceuticals, Inc.
4505 Emperor Boulevard Suite 300
Durham NC 27703 / US
For all designated states
The U.S.A. as represented by the Secretary, Department of Health and Human Services
Office of Technology Transfer
6011 Executive Boulevard, Suite 325
Rockville, MD 20852 / US
[2019/28]
Former [2018/09]For all designated states
Viamet Pharmaceuticals (NC), Inc.
4505 Emperor Boulevard, Suite 300
Durham, NC 27703 / US
For all designated states
The U.S.A. as represented by the Secretary, Department of Health and Human Services
Office of Technology Transfer
6011 Executive Boulevard, Suite 325
Rockville, MD 20852 / US
Former [2017/04]For all designated states
Viamet Pharmaceuticals, Inc.
4505 Emperor Boulevard, Suite 300
Durham, NC 27703 / US
For all designated states
The U.S.A. as represented by the Secretary, Department of Health and Human Services
Office of Technology Transfer
6011 Executive Boulevard, Suite 325
Rockville, MD 20852 / US
Inventor(s)01 / HOEKSTRA, William, J.
7 Treviso Place
Durham, NC 27707 / US
02 / YATES, Christopher, M.
6201 Therfield Drive
Raleigh, NC 27614 / US
03 / BEHNKE, Mark
20300 Whites Ferry Road
Poolesville, MD 20837 / US
04 / ALIMARDANOV, Asaf
5405 Tuckerman Lane
Apt. 718
North Bethesda, MD 20852 / US
05 / DAVID, Scott, A.
11995 Hunt Road
Huntsburg, OH 44046 / US
06 / FRY, Douglas, Franklin
130 E. 212th Street
Euclid, OH / US
 [2017/04]
Representative(s)Adam, Holger
Kraus & Weisert
Patentanwälte PartGmbB
Thomas-Wimmer-Ring 15
80539 München / DE
[2017/04]
Application number, filing date15764771.019.03.2015
[2017/04]
WO2015US21504
Priority number, dateUS201461955633P19.03.2014         Original published format: US 201461955633 P
[2017/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015143180
Date:24.09.2015
Language:EN
[2015/38]
Type: A1 Application with search report 
No.:EP3119755
Date:25.01.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 24.09.2015 takes the place of the publication of the European patent application.
[2017/04]
Type: B1 Patent specification 
No.:EP3119755
Date:06.03.2019
Language:EN
[2019/10]
Search report(s)International search report - published on:KR24.09.2015
(Supplementary) European search report - dispatched on:EP21.07.2017
ClassificationIPC:C07D401/06, C07D213/57, C07F7/18, A61K31/4439, A61K31/41, A61K31/04
[2017/34]
CPC:
C07D401/06 (EP,US); A61K31/4439 (EP,US); C07B57/00 (US);
C07D213/57 (EP,US); C07F7/1804 (EP,US); C07B2200/07 (US)
Former IPC [2017/04]C07D401/06, C07D257/04, A61K31/4439, A61K31/41, A61K31/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/04]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:VERFAHREN FÜR FUNGIZIDE VERBINDUNG[2017/04]
English:ANTIFUNGAL COMPOUND PROCESS[2017/04]
French:PROCÉDÉ DE PRÉPARATION D'UN COMPOSÉ ANTIFONGIQUE[2017/04]
Entry into regional phase15.09.2016National basic fee paid 
15.09.2016Search fee paid 
15.09.2016Designation fee(s) paid 
15.09.2016Examination fee paid 
Examination procedure15.09.2016Examination requested  [2017/04]
15.09.2016Date on which the examining division has become responsible
15.02.2018Amendment by applicant (claims and/or description)
20.03.2018Despatch of a communication from the examining division (Time limit: M04)
18.07.2018Reply to a communication from the examining division
10.09.2018Communication of intention to grant the patent
21.01.2019Fee for grant paid
21.01.2019Fee for publishing/printing paid
21.01.2019Receipt of the translation of the claim(s)
Opposition(s)09.12.2019No opposition filed within time limit [2020/07]
Fees paidRenewal fee
27.03.2017Renewal fee patent year 03
27.03.2018Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.03.2015
AL06.03.2019
AT06.03.2019
CY06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
MK06.03.2019
NL06.03.2019
PL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SI06.03.2019
SK06.03.2019
SM06.03.2019
TR06.03.2019
IE19.03.2019
LU19.03.2019
MT19.03.2019
BE31.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
[2022/31]
Former [2021/32]HU19.03.2015
AL06.03.2019
AT06.03.2019
CY06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
NL06.03.2019
PL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SI06.03.2019
SK06.03.2019
SM06.03.2019
TR06.03.2019
IE19.03.2019
LU19.03.2019
MT19.03.2019
BE31.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2021/26]AL06.03.2019
AT06.03.2019
CY06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
NL06.03.2019
PL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SI06.03.2019
SK06.03.2019
SM06.03.2019
TR06.03.2019
IE19.03.2019
LU19.03.2019
MT19.03.2019
BE31.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2020/29]AL06.03.2019
AT06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
NL06.03.2019
PL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SI06.03.2019
SK06.03.2019
SM06.03.2019
TR06.03.2019
IE19.03.2019
LU19.03.2019
MT19.03.2019
BE31.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2020/17]AL06.03.2019
AT06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
NL06.03.2019
PL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SI06.03.2019
SK06.03.2019
SM06.03.2019
TR06.03.2019
IE19.03.2019
LU19.03.2019
BE31.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2020/12]AL06.03.2019
AT06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
NL06.03.2019
PL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SI06.03.2019
SK06.03.2019
SM06.03.2019
IE19.03.2019
LU19.03.2019
BE31.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2020/09]AL06.03.2019
AT06.03.2019
CZ06.03.2019
DK06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
NL06.03.2019
PL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SK06.03.2019
SM06.03.2019
IE19.03.2019
LU19.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2020/07]AL06.03.2019
AT06.03.2019
CZ06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
MC06.03.2019
NL06.03.2019
PL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SK06.03.2019
SM06.03.2019
LU19.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2020/04]AL06.03.2019
AT06.03.2019
CZ06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
NL06.03.2019
PL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SK06.03.2019
SM06.03.2019
LU19.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
IS06.07.2019
PT06.07.2019
Former [2020/03]AL06.03.2019
AT06.03.2019
CZ06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
NL06.03.2019
PL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SK06.03.2019
SM06.03.2019
LU19.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
PT06.07.2019
Former [2019/52]AL06.03.2019
CZ06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
NL06.03.2019
PL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SK06.03.2019
SM06.03.2019
LU19.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
PT06.07.2019
Former [2019/51]AL06.03.2019
CZ06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
NL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SK06.03.2019
SM06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
PT06.07.2019
Former [2019/49]AL06.03.2019
CZ06.03.2019
EE06.03.2019
ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
NL06.03.2019
RO06.03.2019
RS06.03.2019
SE06.03.2019
SK06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
PT06.07.2019
Former [2019/48]ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
NL06.03.2019
RS06.03.2019
SE06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
PT06.07.2019
Former [2019/47]ES06.03.2019
FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
NL06.03.2019
RS06.03.2019
SE06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
Former [2019/39]FI06.03.2019
HR06.03.2019
LT06.03.2019
LV06.03.2019
NL06.03.2019
RS06.03.2019
SE06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
Former [2019/38]FI06.03.2019
LT06.03.2019
SE06.03.2019
BG06.06.2019
NO06.06.2019
GR07.06.2019
Former [2019/37]FI06.03.2019
LT06.03.2019
SE06.03.2019
NO06.06.2019
GR07.06.2019
Former [2019/34]FI06.03.2019
LT06.03.2019
SE06.03.2019
NO06.06.2019
Former [2019/33]FI06.03.2019
LT06.03.2019
NO06.06.2019
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[A]JP2000344744  (SS PHARMACEUTICAL CO) [A] 1-14* See the whole document. *;
 [A]WO2011133875  (VIAMET PHARMACEUTICALS INC [US], et al) [A] 1-14 * See the whole document. *;
 [A]WO2013110002  (VIAMET PHARMACEUTICALS INC [US]) [A] 1-14 * See the whole document. *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.